Latest "Achillion Reports Preliminary Proof Concept With 4471 Treatment" News Stories - Page: 3

22:12 EDT 21st March 2019 | BioPortfolio

Here are the most relevant search results for "Achillion Reports Preliminary Proof Concept With 4471 Treatment" found in our extensive news archives from over 250 global news sources.

More Information about Achillion Reports Preliminary Proof Concept With 4471 Treatment on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Achillion Reports Preliminary Proof Concept With 4471 Treatment for you to read. Along with our medical data and news we also list Achillion Reports Preliminary Proof Concept With 4471 Treatment Clinical Trials, which are updated daily. BioPortfolio also has a large database of Achillion Reports Preliminary Proof Concept With 4471 Treatment Companies for you to search.

Showing "Achillion Reports Preliminary Proof Concept With 4471 Treatment" News Articles 51–75 of 22,000+

Thursday 21st March 2019

Internal radiation therapy is critical to improving survival among women undergoing multimodal treatment for locally advanced cervical cancer

A recent National Cancer Database (NCDB) study shows the current standard of care for advanced cervical cancer - external beam radiation and chemotherapy in combination with brachytherapy - provides significantly higher overall survival over...

Baxter, bioMérieux partner to improve acute kidney injury treatment

Baxter and bioMérieux announced their collaboration at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) this week. The companies did not disclose additional details about their The post Baxter, bioMérieux partner to improve acute kidney injury treatment appeared first on Compelo Medical Devices - Latest industry news and analysis.

FDA warns of increased mortality rates from drug-coated devices

Concerning reports about potential mortality rates caused by paclitaxel-coated devices have been raised by the FDA.

Jazz gets OK for sleep drug, avoids black box warning

Solriamfetol, a treatment for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea, should launch in mid-2019, Jazz said.

ZipLine Medical Announces New Emergency Department Study Showing Significant Time and Cost Savings, and Superior Patient Satisfaction, with Laceration Closure Using Zip® Surgical Skin Closure

ZipLine Medical, Inc. today announced presentation of positive results from a randomized, prospective clinical study conducted at the Karolinska University Hospital in Stockholm, Sweden demonstrating both clinical and economic benefits of the Zip® Surgical Skin Closure device when used in an emergency medicine setting for lacerations. A poster...

Leafbuyer Technologies, Inc. Announces Greenlight Platform Users Reach Nearly 80,000

Leafbuyer Technologies, Inc. (OTCMKTS: LBUY) (“Leafbuyer” or “the Company”), a leading cannabis technology platform, announced today the number of Greenlight platform users has reached nearly 80,000. The statement follows a March 13, 2019, release announcing Leafbuyer’s rollout of the Greenlight technology in Colorado and Oklahoma. ...

Semtech and Sonova Create New Hearing Aid Solutions for Better IoT Connectivity

Ultra-small, low power wireless radio frequency IC leveraging Fast LoRa® modulation that supports multiple protocols in the 2.4GHz band Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed signal semiconductors and advanced algorithms, and Sonova,

Minimally Invasive TMJ Arthroscopy Offered by Acclaimed Oral Surgeons in Dana Point, CA for Jaw Pain Relief

Dr. Eric Baker and Dr. Tim Betita, acclaimed oral surgeons at Niguel Coast Oral and Facial Surgery, invite patients suffering from TMJ disorder-related jaw pain in Dana Point, CA, to consider the value and benefits of an advanced TMJ arthroscopy when other treatments are ineffective. DANA POINT, Calif. (PRWEB) March 21, 2019 Highly trained and credentialed oral surgeons Dr. Eric Baker and Dr. Tim...

BREAKING: Biogen halts study of closely watched Alzheimer’s drug, a blow to hopes for new treatment 

BREAKING: Biogen halts study of closely watched Alzheimer’s drug, a blow to hopes for new treatment 

Biogen halts studies of closely watched Alzheimer’s drug, a blow to hopes for new treatment

Biogen halts study of closely watched Alzheimer’s drug, a blow to hopes for new treatment.

Merck, NGM Bio extend research deal through 2022

Tucked in that announcement, however, was news Merck has handed back to NGM rights to two candidates for the treatment of obesity.

Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019

A special symposium session, intended to highlight therapeutic advances, will focus on Tumor Treating Fields as a fourth modality in cancer treatment The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at this conference Novocure (NASDAQ: NVCR) announced today 48 presentations on Tumor Treat...

Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate

Findings Presented at European Association of Urology Show Consistent Positive Results for Minimally Invasive UroLift System Treatment Teleflex Incorporated (NYSE:TFX) today announced that multiple studies were presented at the 2019 European Association of Urology (EAU) meeting in Barcelona, Spain, highlighting the effectiveness of the UroLift® System...

Ultrathin Graphene-based Film Offers New Concept for Solar Energy

NewsThe material is 1,000 times thinner than a human hair and can be tuned for use in solar cells, solar desalination, infrared lights and optical components.

Researchers uncover key to greater efficacy in cancer treatment

Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy. In a Nature Communications paper, researchers reveal for the first time that the number...

Aura Biosciences to Present Interim Phase 1b/2 Clinical Data for AU-011 at the International Society of Ocular Oncology 2019 Annual Meeting

Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that interim clinical data from its Phase 1b/2 clinical trial evaluating the safety and efficacy of light-activated AU-011, the Company’s lead product candidate for the primary treatment of primary choroidal melanoma, will be highlighted in an or...

The Netherlands Cancer Institute (NKI) selects Labguru to further pioneering cancer research and treatment

NKI completes institute wide adoption of Labguru to increase efficiency and maximize productivity in the laboratory 21 March 2019, Cambridge, MA — BioData has announced The Netherlands Cancer Institute (NKI) has started an institute wide deployment of its flagship product Labguru. NKI have secured an institutional licence of Labguru’s Electronic Lab Notebook (ELN) for further colla...

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye, today announced the commencement of patient dosing in its Phase 2 clinical tri...

Rare Diseases: PKU GOLIKE® Debuts in Germany

PKU GOLIKE®, the brand new generation of Phenylalanine (PHe)-free medical food for Phenylketonuria (PKU) dietary management, is now available in Germany and Austria, promoted and distributed directly by APR Applied Pharma Research s.a. (APR) through its local subsidiary, APR Deutschland. The company has taken advantage of the 33th Annual Meeting ...

Tool Pouches Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Tool Pouches report provides an independent information about the Tool Pouches industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development.The report woul...

Immunotherapy improves prognosis for women with recurrent ovarian cancer in clinical trial

Results from a clinical trial show that a new immunotherapy treatment, when added to standard chemotherapy, significantly prolongs survival in women with recurrent ovarian cancer. The randomised phase II trial compared overall survival of women who...

Innovus Pharmaceuticals Reports Preliminary Annual 2018 Net Revenue of $24 Million

Preliminary Annual Revenue Increase by 2.7x Compared to Prior Year Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV) today announced preliminary annual 2018 net revenue is estimated to be $24.0 million or approximately 2.7x the annual 2017 net revenue of $8.8 million. Innovus Pharma’s annual 2018 anticipated n...

RevMedx receives CE Mark for XGAUZE® self-expanding gauze

Manufacturer of the revolutionary XSTAT® technology will now have a second sterile wound dressing available in Europe and other International markets WILSONVILLE, Ore. (PRWEB) March 21, 2019 RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in...

AGH Study Advances Tool Used in Determining Treatment for Patients with Pulmonary Arterial Hypertension

Based on results of a research conducted at Allegheny General Hospital, the REVEAL 2.0 risk score calculator is expected to become the most commonly used risk prognostic tool for patients suffering from pulmonary arterial hypertension. PITTSBURGH, Pa. (PRWEB) March 21, 2019 A study conducted by researchers at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN), has demonstrat...

Allergan Announces FDA Approval of AVYCAZ for Pediatric Patients

NewsThe FDA has approved the company's supplemental New Drug Application for AVYCAZ® for the treatment of complicated intra-abdominal infections.

Quick Search


News Quicklinks